RADIOFREQUENCY ABLATION CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

The clinic's name reflects its clinical focus and patient-centered mission. We operate in the U.S. healthcare sector as a specialized outpatient medical clinic launching in 2026 that provides advanced, minimally invasive radiofrequency ablation (RFA) treatments. Our primary services combine cardiac electrophysiology and interventional pain management in a single dedicated center of excellence, using state-of-the-art RFA technology to treat chronic arrhythmias and chronic pain. One-line: A focused outpatient RFA center integrating heart and pain care for better outcomes.

We deliver care through board-certified specialists supported by skilled clinical and administrative staff, offering faster scheduling, streamlined protocols, and lower overhead than large hospital systems. Our business activities include patient evaluation, image-guided RFA procedures, peri-procedural monitoring, and coordinated follow-up care. We target adult patients with chronic cardiac or pain conditions seeking minimally invasive outpatient alternatives. Short-term goals: open the facility and validate clinical pathways in 2026. Long-term goals: sustain superior clinical outcomes, maintain high patient satisfaction, and broaden access to specialized RFA care. One-line: Build a high-quality outpatient alternative that improves outcomes and patient experience.

Problem

Millions of Americans suffer from chronic pain and cardiac arrhythmias that are poorly managed by long-term medication or treated only with high-risk, invasive surgery. Patients with facet joint or sacroiliac joint pain face limited mobility and reduced quality of life, while atrial fibrillation patients often confront major surgical options or prolonged pharmacologic therapy.

The healthcare system lacks specialized, integrated outpatient centers focused on minimally invasive procedures like radiofrequency ablation and catheter-based cardiac treatments. That gap forces patients into chronic opioid or antiarrhythmic use, delayed care, or hospital-based surgery with longer recovery, higher complication rates, and greater cost.

There is a clear need for a dedicated outpatient center that combines cardiac electrophysiology and interventional pain management to provide safer, faster, and more patient-centered minimally invasive care beginning in 2026.

Solution

Millions of Americans suffer chronic pain and cardiac arrhythmias that respond poorly to medication or require high-risk surgery. Our outpatient clinic offers targeted radiofrequency ablation (RFA) using 3D cardiac mapping and modern RFA generators to provide precise, low-risk procedures that shorten recovery, reduce reliance on opioids and antiarrhythmics, and improve patient experience compared with hospital-based care.

We deliver focused, same-site RFA therapies in a dedicated outpatient setting to cut wait times and provide more personalized care.

Mission Statement

Our mission is to improve quality of life for patients with chronic pain and cardiac arrhythmias by delivering the most advanced, minimally invasive radiofrequency ablation treatments in a specialized center of excellence. We provide a safer, more effective alternative to major surgery through clinical expertise, state-of-the-art technology, and compassionate, personalized care that restores function and stabilizes health. We aim to be the premier regional destination recognized for our integrated approach and superior patient outcomes.

Key Success Factors

Success rests on clinical excellence, predictable referrals, advanced technology, and strong financial returns.

• Dual-specialty model maximizes facility utilization and delivers clear value to referring physicians.
• Physician recruitment & retention of board-certified Cardiac Electrophysiologists and Interventional Pain Physicians drives growth.
• State-of-the-art technology—including 3D mapping and fluoroscopy—ensures procedural precision and safety.
• Reliable patient pipeline from a robust referral network plus targeted digital marketing.
• Strong financial performance with a 13-month payback and high EBITDA growth supports expansion.

Financial Summary

The clinic is projected to scale rapidly from first-year revenue of $3,420,000 (2026) to $38,244,000 by 2030 with strong early profitability and quick capital recovery.

Financial requirements: minimum cash $128,000 (required Apr-26); breakeven achieved Jan-26; total payback 13 months; expected IRR 15.73% and ROE 70.95%.

Overall outlook: profitable early, capital-efficient growth with strong investor returns.

Funding Requirements

We require $1,395,000 in initial funding to purchase equipment, complete clinic build-out, and provide a minimum cash reserve for launch in 2026.

The clinic projects $3,420,000 revenue in 2026 rising to $38,244,000 by 2030, EBITDA from $1,932,000 to $30,217,000, breakeven in January 2026, a 13‑month payback, IRR 15.73%, and ROE 70.95%, with a minimum cash reserve of $128,000.